Fortress Biotech Inc
NASDAQ:FBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
Volkswagen AG
F:VOW3
|
DE |
|
N
|
Nasdaq Inc
XMUN:NAQ
|
US |
|
X
|
Xilio Therapeutics Inc
NASDAQ:XLO
|
US |
|
HIAG Immobilien Holding AG
LSE:0QU6
|
CH |
|
A
|
AltaGas Ltd
OTC:ATGFF
|
CA |
|
argenx SE
NASDAQ:ARGX
|
NL |
|
Avis Budget Group Inc
NASDAQ:CAR
|
US |
|
STERIS plc
NYSE:STE
|
IE |
|
B
|
Bank Mandiri (Persero) Tbk PT
XMUN:PQ9
|
ID |
|
R
|
Royal Caribbean Cruises Ltd
XMUN:RC8
|
US |
|
Telefonaktiebolaget LM Ericsson
NASDAQ:ERIC
|
SE |
|
V
|
Volkswagen AG
XHAM:VOW
|
DE |
|
F
|
Fast Retailing Co Ltd
F:FR70
|
JP |
|
Grupo Aeroportuario del Centro Norte SAB De CV
F:G7A
|
MX |
|
Lindblad Expeditions Holdings Inc
NASDAQ:LIND
|
US |
Bankruptcy Probability
Fortress Biotech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Fortress Biotech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
84.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
462.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
180.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
58.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
49.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Fortress Biotech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Fortress Biotech Inc has total debt of 34.6m USD. This includes both short-term (0 USD) and long-term (34.6m USD) debt.
You can find a full breakdown on its Balance Sheet.